Adaptive Biotechnologies Corporation

ADPT

Equity

ISIN US00650F1093 / Valor 48278597

NASDAQ (2024-11-22)

USD 4.69+7.32%

Adaptive Biotechnologies Corporation
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Adaptive Biotechnologies Corporation operates at the intersection of biotechnology and computational science, focusing on harnessing the power of the adaptive immune system to develop clinical applications. The company's Immune Medicine Platform is a pioneering approach that combines proprietary chemistry, computational biology, and machine learning to decode the genetic information of a patient's immune system. By reading and interpreting the vast and complex genetic code of immune receptors, Adaptive Biotechnologies is able to generate and maintain a comprehensive database of immune receptor data. This database is dynamic, expanding with each new patient analysis, and serves as a foundational resource for the development of novel diagnostic and therapeutic tools aimed at managing and treating diseases by leveraging the body's own immune response.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

10.4%1Y

-82.2%3Y

-83.6%5Y

Performance

79.5%1Y

81.2%3Y

75.5%5Y

Volatility